UPDATE: Goldman Sachs Downgrades FMC on Earnings Risk
In a report published Monday, Goldman Sachs analyst Brian Maguire downgraded FMC (NYSE: FMC) from Neutral to Sell, and lowered the price target from $63.00 to $58.00.
In the report, Goldman Sachs noted, “We downgrade FMC shares to Sell from Neutral and lower our 12-month price target by $5 to $58 (7% downside vs. 6% average upside for our universe) as we are concerned that FMC's 2013 EPS guidance and 2015 EPS goals are a high bar. Following multiple recent pre-announcements from peers, we believe there is investor complacency towards 2Q13 EPS risk since FMC has side-stepped prior sector issues; however, now peer warnings are coming specifically at agriculture and crop chemical businesses. Additionally, our channel checks indicate high soda ash inventory levels creating risk to FMC's expected 2H13 pricing rebound.”
FMC closed on Friday at $62.32.
Latest Ratings for FMC
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2022 | Morgan Stanley | Maintains | Equal-Weight | |
Feb 2022 | Wells Fargo | Maintains | Overweight | |
Feb 2022 | Mizuho | Maintains | Buy |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Brian Maguire Goldman SachsAnalyst Color Downgrades Analyst Ratings